filmov
tv
How MD Anderson’s TRACTION Platform is accelerating drug development
Показать описание
The Translational Research to AdvanCe Therapeutics and Innovation in ONcology (TRACTION) platform is on a mission to drive the development of novel cancer medicines to answer unmet patient needs. Working as an industrialized translational biology team, TRACTION scientists use disruptive technologies, cutting-edge disease modeling and unparalleled clinical insights to accelerate drug development and inform clinical trials.
TRACTION is part of MD Anderson’s Therapeutics Discovery division, a multidisciplinary group of clinicians, researchers and drug development experts working collaboratively to develop the next generation of targeted, immune- and cell-based therapies. Their unique structure and position within MD Anderson enables Therapeutics Discovery to bring life-saving medicines to patients quickly, safely and effectively – all under one roof.
TRACTION is part of MD Anderson’s Therapeutics Discovery division, a multidisciplinary group of clinicians, researchers and drug development experts working collaboratively to develop the next generation of targeted, immune- and cell-based therapies. Their unique structure and position within MD Anderson enables Therapeutics Discovery to bring life-saving medicines to patients quickly, safely and effectively – all under one roof.
0:02:35
0:02:46
0:02:04
0:01:45
0:36:16
0:49:52
0:02:54
0:30:53
0:02:26
0:51:29
0:41:28
0:20:07
0:15:21
0:05:17
0:21:00
0:54:54
0:00:15
0:58:23
0:02:43
0:05:08
1:03:33
0:10:35
0:15:36
0:26:03